
44.06 Delayed Data As of Feb 03 | ![]() Today’s Change | 41.45 Today|||52-Week Range 56.32 | -14.02% Year-to-Date |
Previous close | 44.34 |
Today’s open | 44.32 |
Day’s range | 43.89 - 44.39 |
Volume | 23,741,990 |
Average volume (3 months) | 22,056,093 |
Market cap | $248.9B |
Earnings growth (last year) | +41.49% |
Earnings growth (this year) | -39.60% |
Earnings growth (next 5 years) | -0.50% |
Revenue growth (last year) | +23.43% |
P/E ratio | 8.4 |
Price/Sales | 2.93 |
Price/Book | -- |
Today’s change | Today’s % change | |
---|---|---|
ABBVAbbVie | +0.07 | +0.05% |
MRKMerck | -0.00 | -0.00% |
NVONovo Nordisk | +4.40 | +3.32% |
AZNAstraZeneca | 0.00 | 0.00% |
Next reporting date | May 2, 2023 |
EPS forecast (this quarter) | $1.02 |
Annual revenue (last year) | $100.3B |
Annual profit (last year) | $31.4B |
Net profit margin | 31.26% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |